Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis
- Status
- TERMINATED
- Phase
- PHASE2
Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE2
S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039
- Status
- COMPLETED
- Phase
- PHASE3
Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3